Clinical Trial Update: Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating a double bedtime dosing regimen of immediate-release morphine in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Morphine (morphine)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Cancer | Phase 3 | Status: COMPLETED